Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, SHL Telemedicine's Enterprise Value is CHF54.84 Mil.
SHL Telemedicine's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-4.04 Mil. Therefore, SHL Telemedicine's EV-to-EBIT ratio for today is -13.59.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, SHL Telemedicine's Enterprise Value is CHF54.84 Mil.
SHL Telemedicine's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF2.74 Mil. Therefore, SHL Telemedicine's EV-to-EBITDA ratio for today is 20.01.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, SHL Telemedicine's Enterprise Value is CHF54.84 Mil.
SHL Telemedicine's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was CHF50.39 Mil. Therefore, SHL Telemedicine's EV-to-Revenue ratio for today is 1.09.
SHL Telemedicine Enterprise Value Historical Data
The historical data trend for SHL Telemedicine's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of SHL Telemedicine's Enterprise Value
For the Health Information Services subindustry, SHL Telemedicine's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SHL Telemedicine's Enterprise Value Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Enterprise Value distribution charts can be found below:
* The bar in red indicates where SHL Telemedicine's Enterprise Value falls into.
SHL Telemedicine Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
SHL Telemedicine's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHL Telemedicine (LTS:0QMX) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
SHL Telemedicine's current Enterprise Value is CHF54.84 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. SHL Telemedicine's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-4.04 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
SHL Telemedicine's current Enterprise Value is CHF54.84 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. SHL Telemedicine's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF2.74 Mil.
SHL Telemedicine's current Enterprise Value is CHF54.84 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. SHL Telemedicine's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was CHF50.39 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHL Telemedicine Enterprise Value Related Terms
Thank you for viewing the detailed overview of SHL Telemedicine's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0QMX has been successfully added to your 